PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-2.4%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$5.32B
AUM Growth
-$203M
(-3.7%)
Cap. Flow
-$59.9M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
23.94%
Holding
303
New
29
Increased
89
Reduced
98
Closed
32
Top Buys
| 1 |
Union Pacific
UNP
|
$48M |
| 2 |
Gilead Sciences
GILD
|
$37.7M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$33.4M |
| 4 |
CVS Health
CVS
|
$29.7M |
| 5 |
Danaher
DHR
|
$28.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$36.9M |
| 2 |
PNC Financial Services
PNC
|
$34M |
| 3 |
CELG
Celgene Corp
CELG
|
$31.5M |
| 4 |
Accenture
ACN
|
$29.9M |
| 5 |
Waste Connections
WCN
|
$29M |
Sector Composition
| 1 | Technology | 24.14% |
| 2 | Healthcare | 23.21% |
| 3 | Financials | 21.91% |
| 4 | Communication Services | 10% |
| 5 | Industrials | 5.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Box
BOX
$4.75B
| $755K | 0.01% |
61,660
-135,010
| -69% | -$1.65M |
|
|
VTAE
227
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $729K | 0.01% |
110,000
+87,392
| +387% | +$579K |
|
228
Allot
ALLT
$390M
| $635K | 0.01% |
122,039
-138,378
| -53% | -$720K |
|
229
Alkermes
ALKS
$4.94B
| $573K | 0.01% |
16,768
+12,221
| +269% | +$418K |
|
230
Citizens Financial Group
CFG
$22.3B
| $572K | 0.01% |
27,321
-1,459
| -5% | -$30.5K |
|
231
Neurocrine Biosciences
NBIX
$14.3B
| $552K | 0.01% |
+13,961
| New | +$552K |
|
232
Standard BioTools
LAB
$497M
| $520K | 0.01% |
64,492
+13,775
| +27% | +$111K |
|
233
Mastercard
MA
$528B
| $511K | 0.01% |
5,405
-2,945
| -35% | -$278K |
|
234
Brookdale Senior Living
BKD
$1.83B
| $429K | 0.01% |
27,019
-69,648
| -72% | -$1.11M |
|
|
TBRA
235
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $409K | 0.01% |
50,000
+15,939
| +47% | +$130K |
|
|
ADAP
236
Adaptimmune Therapeutics
ADAP
$10.9M
| $407K | 0.01% |
+50,000
| New | +$407K |
|
237
Lexicon Pharmaceuticals
LXRX
$396M
| $359K | 0.01% |
30,000
+5,000
| +20% | +$59.8K |
|
|
CEMP
238
DELISTED
Cempra, Inc.
CEMP
| $350K | 0.01% |
+20,000
| New | +$350K |
|
|
HSTO
239
DELISTED
Histogen Inc. Common Stock
HSTO
| $335K | 0.01% |
783
| – | – |
|
240
Ocular Therapeutix
OCUL
$2.37B
| $290K | 0.01% |
30,000
-5,000
| -14% | -$48.3K |
|
|
NBRV
241
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $269K | 0.01% |
120
+76
| +173% | +$170K |
|
|
XLNX
242
DELISTED
Xilinx Inc
XLNX
| $244K | ﹤0.01% |
+5,147
| New | +$244K |
|
|
VRML
243
DELISTED
Vermillion, Inc.
VRML
| $147K | ﹤0.01% |
100,000
| – | – |
|
244
Acadia Pharmaceuticals
ACAD
$4.26B
| – | – |
-14,595
| Closed | -$520K |
|
245
Ambarella
AMBA
$3.54B
| – | – |
-71,040
| Closed | -$3.96M |
|
246
Advanced Micro Devices
AMD
$245B
| – | – |
0
| – | – |
|
247
AutoNation
AN
$8.55B
| – | – |
-376,144
| Closed | -$22.4M |
|
248
Cardinal Health
CAH
$35.7B
| – | – |
-37,000
| Closed | -$3.3M |
|
249
Cognex
CGNX
$7.55B
| – | – |
-450,402
| Closed | -$7.61M |
|
250
Centene
CNC
$14.2B
| – | – |
-830,650
| Closed | -$27.3M |
|